Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer: An Update, An Issue of Urologic Clinics
Title | Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer: An Update, An Issue of Urologic Clinics PDF eBook |
Author | Sam S. Chang |
Publisher | Elsevier Health Sciences |
Pages | 330 |
Release | 2013-05-28 |
Genre | Medical |
ISBN | 1455773727 |
Of the three types of bladder cancer, Non-Muscle Invasive Bladder Cancer (NMIBC) is the most common form and is diagnosed in over 70% of cases. This issue of the Urologic Clinics focuses on NMIBC and includes articles on periopertive chemotherapy, office fulguration, TURBT, surveillance strategies, and radiation therapy in type-1 tumors.
Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer: an Update, an Issue of Urologic Clinics
Title | Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer: an Update, an Issue of Urologic Clinics PDF eBook |
Author | Sam S. Chang |
Publisher | |
Pages | 0 |
Release | 2013-04-05 |
Genre | Bladder |
ISBN | 9781455773459 |
Of the three types of bladder cancer, Non-Muscle Invasive Bladder Cancer (NMIBC) is the most common form and is diagnosed in over 70% of cases. This issue of the Urologic Clinics focuses on NMIBC and includes articles on periopertive chemotherapy, office fulguration, TURBT, surveillance strategies, and radiation therapy in type-1 tumors.
Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer
Title | Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer PDF eBook |
Author | Sam S. Chang |
Publisher | |
Pages | 0 |
Release | 2013 |
Genre | Urology |
ISBN |
Urologic An issue of Salvage therapies for Non-Muscle Invasive Bladder Cancer, E-Book
Title | Urologic An issue of Salvage therapies for Non-Muscle Invasive Bladder Cancer, E-Book PDF eBook |
Author | Badrinath Konety |
Publisher | Elsevier Health Sciences |
Pages | 240 |
Release | 2019-12-03 |
Genre | Medical |
ISBN | 032372261X |
Together with Consulting Editor Dr. Samir Taneja, Dr. Badrinath Konety has put together a comprehensive issue that addresses Salvage therapies for Non-Muscle Invasive Bladder Cancer. Expert authors have contributed clinical review articles on the following topics: BCG salvage therapy: Definition and context; Who will respond to BCG? Predictors and nomograms; Identification of candidates for salvage therapy: Definition of BCG “Failure ; Predictors of response to Intravesical therapy; Precision medicine for NMIBC; Salvage therapy using BCG derivatives or single agent chemotherapy; Intravesical heated Mitomycin: Biology and clinical utility; Mitomycin derivatives in the salvage setting; Combination intravesical therapy; Intravesical gene therapy; Immunoncology as salvage therapy; Role of IDO inhibitors in salvage therapy; and Novel agents for intravesical therapy. Readers will come away with the clinical information they need to improve outcomes in patients with bladder cancer.
Management of Non-Muscle Invasive Bladder Cancer
Title | Management of Non-Muscle Invasive Bladder Cancer PDF eBook |
Author | Sanchia S. Goonewardene |
Publisher | Springer Nature |
Pages | 377 |
Release | 2019-10-23 |
Genre | Medical |
ISBN | 3030286460 |
This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors. Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.
Current Management of Invasive Bladder and Upper Tract Urothelial Cancer, An Issue of Urologic Clinics, E-Book
Title | Current Management of Invasive Bladder and Upper Tract Urothelial Cancer, An Issue of Urologic Clinics, E-Book PDF eBook |
Author | Jeffrey M. Holzbeierlein |
Publisher | Elsevier Health Sciences |
Pages | 266 |
Release | 2018-04-28 |
Genre | Medical |
ISBN | 0323583792 |
Dr. Holzbeierlein has created an issue devoted to the current knowledge and best practice of Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. Top expert authors have written clinical reviews on the following topics: Current Staging Strategies for Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma; Neoadjuvant Chemotherapy for MIBC and Upper Tract UCC; Bladder Preservation Therapy for MIBC; Pre-Operative and Intraoperative Optimization of the Cystectomy Patient; Robotic Cystectomy; Robotic Nephroureterectomy; Organ Sparing Cystectomy; Lymphadenectomy for MIBC and Upper Tract UCC; ERAS Pathways; Follow-up Management of Cystectomy Patients; Quality of Life after Cystectomy; Endoscopic Approaches to Upper Tract UCC; Adjuvant Therapy in MIBC and Upper Tract UCC; and Immunotherapy in MIBC and Upper Tract UCC. The urologist will have the clinical information he or she needs to treat these patients so as to optimize outcomes.
Management of High Grade Bladder Cancer: A Multidisciplinary Approach, An Issue of Urologic Clinics
Title | Management of High Grade Bladder Cancer: A Multidisciplinary Approach, An Issue of Urologic Clinics PDF eBook |
Author | Arjun Balar |
Publisher | Elsevier Health Sciences |
Pages | 137 |
Release | 2015-06-14 |
Genre | Medical |
ISBN | 032337624X |
The Guest Editors have assembled top key opinion leaders to provide current reviews on the multidisciplinary approach to the management of high-grade bladder cancer. Articles are devoted to fluorescence cystoscopy, confocal laser endomicroscopy, narrow band imaging; Novel therapeutic approaches for recurrent nonmuscle invasive bladder cancer; Trimodality therapy in bladder cancer; the data and the reality of perioperative chemotherapy in muscle invasive bladder cancer; radical transurethral resection alone, robotic or partial cystectomy or extended lymphadenectomy: Neoadjuvant paradigm for drug development in muscle invasive bladder cancer; Novel biomarkers to predict response and prognosis in localized bladder cancer; Immunotherapy in Advanced/Metastatic Urothelial Cancer ; and Adjuvant Chemotherapy in High Grade Upper Tract Urothelial Cancer.